Inventor
MULHOLLAND KEITH RAYMOND
GB16 patents
⚠️ This page may combine multiple inventors who share the name “MULHOLLAND KEITH RAYMOND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM PLC
13 patentsUS5990133ANov 23, 1999
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC89 citations95
US5905080AMay 18, 1999
Amide and urea derivatives as 5HT1D receptor antagonists
SMITHKLINE BEECHAM PLC61 citations93
US5972937AOct 26, 1999
Heterocyclic compounds possessing 5HT2C receptor antagonist activity
SMITHKLINE BEECHAM PLC28 citations92
US5741801AApr 21, 1998
5-HT4 receptor antagonist
SMITHKLINE BEECHAM PLC35 citations92
US5726187AMar 10, 1998
N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC40 citations91
US6638953B2Oct 28, 2003
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC9 citations73
US5919932AJul 6, 1999
Biphenylamide derivatives as 5HT1D antagonists
SMITHKLINE BEECHAM PLC7 citations73
US5708174AJan 13, 1998
Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC10 citations72
US7232902B2Jun 19, 2007
Process to prepare (1-carboxymethyl)-pyrimidinone compounds
SMITHKLINE BEECHAM PLC7 citations67
US6235758B1May 22, 2001
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC2 citations62
US5872134AFeb 16, 1999
5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC4 citations62
US6114329ASep 5, 2000
5-HT4 receptor antagonists useful in the treatment of gastroinstestinal, cardiovascular and CNS disorders
SMITHKLINE BEECHAM PLC0 citations52
US5786372AJul 28, 1998
Heteroaryl compounds used as pharmaceuticals
SMITHKLINE BEECHAM PLC1 citations52